Supplementary Methods

Identification of Arhgap17
Gt(RRN062)Byg allele and generation of Arhgap17 mutant mice
Gene trap ES cell line, Gt(RRN062)Byg (129P2/OlaHsd origin), was obtained from International Gene Trap Consortium. Using genomic DNA of ES cells as a template, the exact structure of
Arhgap17
Gt(RRN062)Byg allele was identified by PCR sequencing. For 5' junction identification, 5'-GACCGAAGTCCTCAGTGAAGATC-3' (forward) specific for exon 2 of Arhgap17 and 5'-GGGAAAGAGGGCTCTGTCCT-3' (reverse) for gene trap vector (pGT0lxf) were used for PCR primers. For 3' junction identification, 5'-CTCACCGGCTCCAGATTTATCA-3' (forward) for pGT0lxf
and 5'-CGTCAGAGCTCTAGGCTGGA-3' (reverse) for Arhgap17 were used for PCR primers. PCR
sequencing of Arhgap17
Gt(RRN062)Byg allele of ES cells revealed that splicing acceptor from gene trap vector was inserted into intron 2 of Arhgap17 (Supplementary Figure 1A) . Sequencing of RT-PCR product of gene trap allele showed that exon 2 of Arhgap17 was followed by En2 coding leader in gene trap vector as expected, which would code for fusion protein tagging with 31 amino acids of Arhgap17 N-terminal region.
ES cells were injected into C57BL/6J-derived blastocysts to generate chimeric mice and chimeric mice were further bred to C57BL/6J female to obtain heterozygous mice. Heterozygous mice were maintained congenic on C57BL/6J background more than 10 generations. Genotypes were determined by PCR with three primers (Supplementary Figure 1A) : Arhgap17-S1, 5'-GAGATGCATGATGGGATTGCG-3' (forward); Arhgap17-AS1, 5'-CGTCAGAGCTCTAGGCTGGA-3' (reverse); En2-AS1, 5'-CCGGAGCGGATCTCAAACTC-3'
(reverse). Arhgap17-S1 and Arhgap17-AS1 amplify the wild-type allele and Arhgap17-S1 and En2-AS1 3 amplify the mutant allele, respectively. Genotypes of offspring were determined by PCR followed by agarose gel electrophoresis (Supplementary Figure 1B) . Homozygous mutant mice with
Arhgap17
Gt ( 
RNA purification and RT-PCR
Total RNA was isolated from tissues using Trizol reagent (Life Technologies) as suggested by manufacturer. Reverse transcription and PCR were performed as described previously.
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The primers for PCR are Arhgap17-E2, 5'-GACCGAAGTCCTCAGTGAAGATC-3' (forward); Arhgap17-E4, 5'-
(reverse). Arhgap17-E2 and Arhgap17-E4 amplify cDNA of the endogenous mRNA, and Arhgap17-E2
and β-geo amplify cDNA of the mutant mRNA, respectively. 
Cell proliferation and apoptosis in the intestine
Tissues were labeled with 10 mM BrdU (Sigma-Aldrich) for 2 hours and flushed with PBS before collection of tissues. The paraffin sections were immunostained with a BrdU staining kit or a TUNEL staining kit as described previously.
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BrdU or TUNEL stained slides were examined under ECLIPSE 80i light microscope (Nikon) and analyzed with NIS-Elements BR 3.2 imaging software. Twenty crypts per mouse were assessed for analysis.
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Histological scoring after DSS treatment
The severity of mucosal injury was graded on a scale of 0 to 3: grade 0, normal; grade 1, partial destruction of crypts; grade 2, complete loss of crypts; and grade 3, complete loss of crypts and epithelial cells.
1,2
The histological score was determined by multiplying the portion of injured surface by the grade of severity. Two different regions of proximal, middle and distal colon were used for histological scoring, and the histological scores from individual mice were determined by adding all six values. Histological scoring was performed in a blinded fashion.
Immunoprecipitation (IP) and western blot analysis
The extract of intestinal tissues was prepared by homogenization in RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1% lgepal CA-630, 0.5% sodium deoxycholate and 0.1% SDS) supplemented with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin and 10 μg/ml aprotinin) and phosphatase inhibitors (1 mM Na 3 VO 4 , 1 mM NaF and 10 mM β-glycerophosphate). The cleared extract (300 μg) was adjusted to 0.8 ml with HNTG buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol) containing protease and phosphatase inhibitors. The mixture was incubated with 2 μg of arhgap17 (sc-160146, Santa Cruz Biotech) antibody overnight at 4°C, followed by incubation with 20 μl of protein G beads (Pierce) for 3 hours at 4°C. The mixture was washed with HNTG buffer 4 times, eluted with 20 μl of 2× SDS sample buffer by heating 95°C for 3 min and used for western blotting as described previously, 1 using anti-arhgap17 antibody (sc-160145, Santa Cruz Biotech). For straight western blotting, tissue collection, homogenization, protein quantification, SDS-PAGE, western blotting and quantification of blots were performed as described previously.
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The antibodies used were: β-actin (AC-15, Sigma-Aldrich); anti-Tff3 antibody (kindly from Dr. Nam).
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LacZ staining
The Arhgap17 expression in tissues was determined by β-galactosidase (LacZ) staining. For whole mount LacZ staining, embryos were fixed in 0.25% glutaraldehyde, 5 mM EGTA and 2 mM MgCl 2 in PBS for 10 minutes at 4°C. After rinsing with detergent solution (2 mM MgCl 2 , 0.02% Igepal CA-630, 0.01% sodium deoxycholate in PBS) three times, embryos were stained with X-gal staining solution 1 for 2 to 3 hours at 37°C and examined under dissecting microscope. To analyze the endogenous Arhgap17 expression in adult, tissues collected from arghap17-deficient mice were fixed, frozen-sectioned and stained with X-gal as described previously.
1
The X-gal-stained tissues were counterstained with 0.1× (v/v) Harris hematoxylin (Sigma-Aldrich) followed by eosinY staining not to disturb the X-gal staining.
The image was visualized with light microscope.
The primary antibodies for immunofluorescence and immunohistochemistry
The primary antibodies were anti-E-cadherin (610181, BD Biosciences), anti-β-catenin antibody (sc-7199, Santa Cruz Biotech), anti-occludin antibody (711500, Life Technologies), anti-ZO-1 (402200, Life Technologies), anti-TNF antibody (ab6671, Abcam), anti-Tff3 antibody (kindly from Dr. Nam). Factin was stained with Alexa 568-conjugated Phalloidin (A12380, Life Technologies). 
Co-immunofluorescence staining of E-cadherin and F-actin
Migration of epithelial cells in the intestine
Tissues were labeled with 10 mM BrdU for 30 hours and flushed with PBS before collection of tissues. The paraffin sections were immunostained with a BrdU staining kit and cell migration was analyzed by measuring the length of far upstream BrdU-stained epithelial cells from the crypt using NIS-Elements BR 3.2 imaging software (Nikon). Twenty villus or ten crypts per mouse were assessed for analysis. 
